Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-14

Clinical Trial Update: Pomegranate Extract Supplementation in Colorectal Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

An update on a trial evaluating pomegranate extract supplementation in colorectal cancer patients. The Phase 1 and Phase 2 studies have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pomegranate extract supplementation

Snippet

Sponsor: National Research Council, Spain | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED